Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$150.1M
-6.8% from 2023
Prescriptions
315K
$476.16 per claim
Patients
77K
48,027 prescribers
Total spending, 2024
$150.2M
$1,947.91 per patient
Medicare prescription drug plans paid $150.1M for Belsomra in 2024, for 315,286 prescriptions and refills to 77,066 patients (down 6.8% from 2023). The average cost per claim was $476.16.
California had the highest Medicare cost for Belsomra in 2024: $14.3M for 29,948 claims, followed by Texas ($12.5M).
Carmelo E Herrero Lugo, psychiatry in Humacao, PR, had the highest Medicare cost for Belsomra in 2024: 521 claims costing $234K.
Belsomra is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Carmelo E Herrero Lugo Humacao, PR | Psychiatry | 521 | 119 | $234K |
| James Rini Mobile, AL | Neurology | 386 | 84 | $177K |
| Robert O Morton Ada, OK |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 43,028 | 280,729 | 70,580 | $130.0M |
| 2023 | 50,442 | 328,963 | 86,353 | $161.1M |
| 2024 | 48,027 | 315,286 | 77,066 | $150.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Psychiatry |
| 437 |
| 58 |
| $168K |
| Jose E Pagan Corpus Christi, TX | Psychiatry | 373 | 76 | $165K |
| Ernesto Zilberberg North Andover, MA | Psychiatry | 348 | 68 | $164K |
| Victor Lyapis Colusa, CA | General Practice | 344 | 57 | $151K |
| Jyh-Haur Lu Flushing, NY | Neurology | 345 | 100 | $148K |
| Milagros Ortiz Humacao, PR | Psychiatry | 315 | 49 | $143K |
| Kenia Castro Hialeah, FL | Psychiatry | 245 | 48 | $107K |
| Laura E Dauenhauer Milwaukee, WI | Psychiatry | 193 | 35 | $103K |
| Anna Potash Brooklyn, NY | Psychiatry | 216 | 35 | $91K |
| John C Strunk Dothan, AL | Psychiatry | 204 | 37 | $90K |
| Marlon P Quinones San Antonio, TX | Psychiatry | 193 | 33 | $90K |
| David A Medina Orlando, FL | Psychiatry | 185 | 30 | $88K |
| Jennifer Holeman Oklahoma City, OK | Anesthesiology | 195 | 53 | $88K |
| Tsilya Bass West Hollywood, CA | Psychiatry | 202 | 25 | $86K |
| John A Damergis Jr. Bloomington, MN | Sleep Medicine | 117 | 37 | $83K |
| Roberto M Nieto Mansfield, TX | Neurology | 145 | 44 | $81K |
| Madeline Santos-Carlo Bayamon, PR | Psychiatry | 178 | 50 | $80K |
| Luis J Olivera-Rodriguez Orlando, FL | Psychiatry | 156 | 30 | $77K |
| Anissa V Hernandez Rivera Humacao, PR | Psychiatry | 161 | 29 | $72K |
| Hung T Pham Philadelphia, PA | Internal Medicine | 157 | 41 | $70K |
| Josiah S Matthews IV Albany, GA | Interventional Pain Management | 152 | 34 | $69K |
| James Cuellar Wentzville, MO | Family Practice | 99 | 39 | $69K |
| Jason L Maxfield Joplin, MO | Sleep Medicine | 142 | 23 | $66K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 315,401 | $150.2M |